Tarena Int'l (TEDU) – Company Press Releases
-
TCTM Announces Corporate Name Change
-
Tarena to Change Ticker Symbol and Ring Nasdaq Opening Bell on January 10, 2024
-
Tarena to Hold an Extraordinary General Meeting on February 20, 2024
-
/C O R R E C T I O N -- Tarena International, Inc./
-
Tarena Signs Equity Transfer Agreement to Dispose of Professional Education Business
-
Tarena Receives Approval to Transfer to Nasdaq Capital Market
-
Tarena Announces the Results for the Second Quarter of 2023
-
EHang Reports Second Quarter 2023 Unaudited Financial Results
-
Tarena to Report Second Quarter 2023 Financial Results on August 28, 2023
-
Tarena Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
-
Tarena International, Inc. Announces the Results for the First Quarter of 2023
-
Tarena to Report First Quarter 2023 Financial Results on June 12, 2023
-
Presenting on the Emerging Growth Conference on May 3 Register Now
-
Tarena Filed 2022 Annual Report on Form 20-F
-
Tarena International, Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023
-
Tarena International, Inc. Announces the Unaudited Results for the Fourth Quarter and Fiscal Year of 2022
-
Tarena to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 27, 2023
-
Tarena Becomes One of the First Partners of Baidu's ERNIE Bot Ecosystem
-
Tarena to Present at Upcoming Investor Conference
-
Tarena Announces Changes to Board Composition
-
Tarena International, Inc. Announces the Results for the Third Quarter of 2022 and a Share Repurchase Program
-
Tarena to Report Third Quarter 2022 Financial Results on November 29, 2022
-
Tarena Added to the List of "Approved Education Providers" published by China's Ministry of Education
-
Tarena to Present at Upcoming Investor Conferences
-
Tarena to Ring Nasdaq Stock Market Opening Bell on September 29, 2022
-
Tarena Announces the Results for the Second Quarter of 2022 with revenues exceeding guidance and appoints New Chief Financial Officer
-
Tarena to Report Second Quarter 2022 Financial Results on Aug 16, 2022
-
Tarena International, Inc. Extends Its Share Repurchase Program
-
Tarena Regains Compliance with Nasdaq Listing Rules
-
Tarena International, Inc. Announces the Results for the First Quarter of 2022, Net Profit Reaches RMB 27.1 Million and Loss Ends
-
Tarena International, Inc. Announces the Results for the First Quarter of 2022
-
Tarena to Report First Quarter 2022 Financial Results on May 17, 2022
-
Tarena Filed 2021 Annual Report on Form 20-F
-
Tarena Renewal in FY 2021: Full-Year Net Revenue Up 25.7%, Q4 Positive Cash Flow 130 Million
-
Tarena International, Inc. Announces the Results for the Fourth Quarter and Fiscal Year of 2021
-
Tarena to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 16, 2022
-
Tarena Announces Changes to Board Composition
-
Tarena Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
-
Tarena International, Inc. Announces Share Repurchase Program
-
Tarena Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price and Expects to Regain Compliance after the ADS Ratio Change
-
Tarena International, Inc. Announces Plan to Implement ADS Ratio Change
-
Tarena International, Inc. Announces the Results for the Third Quarter of 2021
-
Tarena and the Buyer Group Agree to Terminate Merger Agreement
-
Tarena to Report Third Quarter of 2021 Financial Results on November 23, 2021
-
Tarena International, Inc. Entered into a Strategic Cooperation Agreement with Xueda Education Group
-
Tarena Delivers Notice of Intent to Terminate Merger Agreement Due to Breach by Parent and Merger Sub
-
Tarena International, Inc. Announces the Results for the Second Quarter of 2021
-
Tarena to Report Second Quarter of 2021 Financial Results on September 24, 2021
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tarena, Orphazyme, DiDi, and CorMedix and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tarena, Orphazyme, DiDi, and CorMedix and Encourages Investors to Contact the Firm
Back to TEDU Stock Lookup